Friday, December 22, 2017

News Recap:

Eight Genotypes: Did you know that there are now 8 genotypes and 84 subtypes of HCV that have been identified?  On the one hand this is terrible news; but on the other, a study presented at AASLD 2017 found that Vosevi was effective against them all.  Eight Genotypes and 84 Subtypes of HCV.

Telemedicine: Did you know that Project ECHO (Extension for Community Health Outcomes), a fast-growing international telemedicine program, has locations in Montreal, Toronto and Vancouver for hepatitis C? Is Project ECHO the Telemedicine Model That Healthcare Is Missing?

Transplanting infected livers:  Did you know that a study by Massachusetts General Hospital (MGH) investigators found that the availability of directly-acting antiviral (DAA) drugs to treat hepatitis C virus (HCV) infection could allow the transplantation of livers from HCV-positive donors into HCV-negative recipients without posing undue risk? Should uninfected patients accept hepatitis C-infected livers to reduce waiting time?

Treating Older Patients:  Did you know that data published in the Journal of the American Geriatrics Society suggest direct-acting antivirals (DAAs) are safe and effective at achieving a sustained virologic response in older adults with hepatitis C virus (HCV)-related fibrosis or cirrhosis? Efficacy of Direct-Acting Antivirals for HCV Clearance in Older Adults


Job Posting
HepCBC is seeking an Operations Manager. The position is part-time/~20 hours per week (limited-time contract until July 2018).  The deadline for applications is December 31, 2017. You can read the complete job description here.


Happy Holidays